#chemical industry
Here is a roundup on some of the most recent research and scientific efforts against the coronavirus.
Novartis:
Novartis has reached an agreement with the US Food and Drug Administration to proceed with a phase III clinical trial of hydroxychloroquine in hospitalized Covid-19 patients. The large trial will be conducted at more than a dozen sites in the US and tested on approximately 440 patients to evaluate the use for this treatment.
Additionally, Norvatis plans to make its hydroxychloroquine intellectual property available to support broad access to hydroxychloroquine. Read more here.
Causaly
Causaly, an innovative technology company that harnesses AI to interpret vast databases of biomedical knowledge, is collaborating with UCL academics to increase research on potential therapeutic agents and the identification of biomarkers.
Several researchers and research groups within UCL have been granted access to Causaly technology, allowing them the access to rapidly analyse and derive insights from biomedical literature.
Read more here.
Vaccine Taskforce
As part of the UK’s wider efforts to support the development of a vaccine, a new government-led Vaccine Taskforce will soon be launched to drive forward the manufacturing and research efforts to fight the virus.
The government will review regulations to facilitate fast and safe vaccine trials, as well as operational plans, to ensure a vaccine can be produced at a large scale when it becomes available. Industry and academic institutions will be given the resources and support needed.
Business Secretary Alok Sharma said, ‘UK scientists are working as fast as they can to find a vaccine that fights coronavirus, saving and protecting people’s lives. We stand firmly behind them in their efforts. The Vaccine Taskforce is key to coordinating efforts to rapidly accelerate the development and manufacture of a potential new vaccine.’ Read more here.
A new biosensor for the COVID-19 virus
Research teams at Empa and ETH Zurich have developed an alternative test method in the form of an optical biosensor. The sensor made up of gold nanostructure, known as gold nonoislands on a glass substrate, combines two different effects to detect covid-19: an optical and a thermal one.
According to the release, ‘Artificially produced DNA receptors that match specific RNA sequences of the SARS-CoV-2 [virus] are grafted onto the nanoislands,’ and researchers will then use the optical phenomena, - localised surface plasmon resonance - to monitor the presence of the virus.
The biosensor is not yet ready to be used to monitor and detect COVID-19, however tests showed the sensor can distinguish between very similar RNA sequences of SARS-CoV-2 virus and its relative, SARS-Cov. Read more here.
For more information and more updates on the coronavirus, please visit our hubhere.
One of the most beloved flowers in China (and elsewhere) this small tree was planted here in the SCIence garden to represent the Chinese UK group. It is in bloom from late winter and the bright pink flowers have a strong perfume. It is growing in the centre at the back of the main area of the garden.
There are 309 accepted species in the genus Prunus listed on the Plants of the World Online database (plantsoftheworldonline.org). The genus is distributed mainly across the Northern temperate zones but there are some tropical species.
The genus Prunus is generally defined based on a combination of characteristics which include: a solitary carpel (the structure enclosing the ovules – a combination of the ovary, style and stigma) with a terminal style, a fleshy drupe (fruit), five sepals and five petals and solid branch pith. The drupe contains a single, relatively large, hard coated seed (stone) – familiar to us in cherries, apricots, nectarines, peaches etc
This particular species, Prunus mume, originates from southern China in the area around the Yangtze River. The ‘Beni-chidori’ cultivar has been given an Award of Garden Merit by the Royal Horticultural Society.
Over 300 different cultivars of this species have been recorded in China, perhaps not surprisingly for a plant that has been domesticated for thousands of years due to its floral beauty. A recent study on the genetic architecture of floral traits across the cultivars of this species was published in Nature Communications.1
Prunus mume was introduced from China into Japan, Korea, Taiwan and Vietnam and it is now fully integrated into the cuisines of all these countries. In addition to its uses in many foodstuffs and drinks, extracts from the fruit are also widely used in traditional Chinese medicine and in the traditional medicines in Korea and Japan. Anti-bacterial, anti-oxidative, anti-inflammatory and anti-cancer properties have all been ascribed to the extract which has been used to treat tiredness, headaches, constipation and stomach disorders amongst other things. A recent review published in the Journal of Ethnopharmacology2 gathers together information from literature reports on the anti-cancer activity of Prunus mume fruit extract.
One standardised extract in particular (MK615) has shown antitumour activity against most common cancer types.
The anti-cancer activity has not been ascribed to a particular component. Compounds isolated from the extract include ursolic acid, amygdalin, prunasin, chlorogenic acid, mumefural and syringaresinol.
Like all the plants in the SCIence garden – there’s a lot more to this one than just its ornamental beauty.
References
1. Zhang, Q., Zhang, H., Sun, L. et al. The genetic architecture of floral traits in the woody plant Prunus mume. Nat Commun 9, 1702 (2018). https://doi.org/10.1038/s41467-018-04093-z
2. Bailly, C. Anti-cancer properties of Prunus mume extracts. J Ethnopharmacology 246,2020, 112215. https://doi.org/10.1016/j.jep.2019.112215
Written by Alison Foster: Botanical Horticulturist and Science Communicator